Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgery
- 25 April 2005
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 8 (2), 119-124
- https://doi.org/10.1111/j.1463-1326.2005.00494.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk FeaturesCirculation, 2004
- Treatment of Saphenous Vein Bypass Grafts With Ultrasound ThrombolysisCirculation, 2003
- Survival After Coronary Revascularization in the ElderlyCirculation, 2002
- Ablating Adenovirus Type 5 Fiber–CAR Binding and HI Loop Insertion of the SIGYPLP Peptide Generate an Endothelial Cell-Selective AdenovirusMolecular Therapy, 2001
- ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)Journal of the American College of Cardiology, 1999
- Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5Science, 1997
- Pathophysiology of vein graft failure: A reviewEuropean Journal of Vascular and Endovascular Surgery, 1995
- Coronary artery disease and coronary artery bypass grafting in diabetic patients aged ≥65 years (report from the Coronary Artery Surgery Study [CASS] registry)The American Journal of Cardiology, 1994
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993
- Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteriesProgress in Cardiovascular Diseases, 1991